Page 5 - Erick Rowinsky News Today

Flputnam Investment Management Co. reduced its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 8.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,931 shares of the biotechnology company’s stock after selling 185 shares during the […]

Flputnam Investment Management Co. decreased its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 8.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,931 shares of the biotechnology company’s stock after selling 185 shares during the […]

Tobam reduced its position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 7.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,922 shares of the biotechnology company’s stock after selling 933 shares during the quarter. Tobam’s holdings in Biogen were worth […]

Tritonpoint Wealth LLC bought a new position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) during the fourth quarter, Holdings Channel reports. The fund bought 2,023 shares of the biotechnology company’s stock, valued at approximately $523,000. Other institutional investors have also recently added to or reduced their stakes in the company. Norges Bank bought […]

Tritonpoint Wealth LLC acquired a new position in Biogen Inc. (NASDAQ:BIIB – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,023 shares of the biotechnology company’s stock, valued at approximately $523,000. Other large investors have also recently bought and sold […]

Shares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twenty-seven analysts that are covering the firm, Marketbeat Ratings reports. Eight analysts have rated the stock with a hold recommendation and nineteen have given a buy recommendation to the company. The average 12-month price objective […]

Camelot Portfolios LLC raised its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 81.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,000 shares of the biotechnology company’s stock after acquiring an additional 900 shares during […]

Altfest L J & Co. Inc. raised its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 13.8% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,433 shares of the biotechnology company’s stock after buying an additional 174 shares during the period. Altfest L […]

Wellington Management Group LLP increased its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.5% in the third quarter, Holdings Channel reports. The institutional investor owned 5,374,310 shares of the biotechnology company’s stock after acquiring an additional 27,951 shares during the period. Wellington Management Group LLP’s holdings in Biogen were worth $1,381,251,000 at the […]

Carmignac Gestion cut its holdings in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 309,100 shares of the biotechnology company’s stock after selling 1,000 shares during the quarter. Biogen accounts for approximately 1.5% of […]